| FRANKLIN GENOMIC ADVANCEMENTS I (ACC) USD | RVI BIOTECNOLOGÍA | 41,23% | 27,12% | · | · |
| FRANKLIN GENOMIC ADVANCEMENTS N (ACC) EUR | RVI BIOTECNOLOGÍA | 39,19% | 20,25% | · | · |
| FRANKLIN GENOMIC ADVANCEMENTS N (ACC) USD | RVI BIOTECNOLOGÍA | 38,85% | 20,89% | · | · |
| FRANKLIN GENOMIC ADVANCEMENTS W (ACC) USD | RVI BIOTECNOLOGÍA | 41,13% | 26,81% | · | · |
| FRANKLIN GLOBALAMENTAL STRATEGIES W (ACC) EUR | MIXTO FLEXIBLE | 10,39% | 33,50% | 27,77% | · |
| FRANKLIN GLOBALAMENTAL STRATEGIES W (ACC) EUR-H1 | MIXTO FLEXIBLE | 7,22% | 34,87% | 11,29% | · |
| FRANKLIN GLOBALAMENTAL STRATEGIES W (YDIS) EUR | MIXTO FLEXIBLE | 8,05% | 25,47% | 16,41% | · |
| FRANKLIN GLOBAL CONVERTIBLE SECURITIES W (ACC) CHF-H1 | RFI GLOBAL CONVERTIBLES | 12,89% | 36,90% | 23,42% | · |
| FRANKLIN GLOBAL CONVERTIBLE SECURITIES W (ACC) EUR-H1 | RFI GLOBAL CONVERTIBLES | 15,61% | 43,37% | 16,41% | · |
| FRANKLIN GLOBAL CONVERTIBLE SECURITIES W (ACC) USD | RFI GLOBAL CONVERTIBLES | 18,72% | 42,46% | 32,88% | · |
